Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Russo | MEDLINE | ID: mdl-21446174

RESUMO

AIM: To study efficacy of complex therapy of urogenital infections caused by Chlamydia and Mycoplasma using immunomodulator Superlimph. MATERIALS AND METHODS: Fifty males and thirty six females ages 22 - 47 years old with chronic urogenital infections--cervicitis and vulvovaginitis (females), prostatitis (males)--were studied. PCR and bacteriologic methods were used for diagnostics of mixed infection and microbiota efficiency. Patients were divided on 3 groups according to treatment protocol. Twenty patients (group 1)--standard therapy (josamycin), 48 patients received immunomodulator (suppositorium) before treatment with josamycin (group 2), 18 patients were simultaneously treated with josamycin and immunomodulator (group 3). RESULTS: Combinations of Chlamydia trachomatis, Ureaplasma urealyticum, Gardnerella vaginalis and Mycoplasma genitalium were identified in 30 - 35% of cases before treatment. After treatment with josamycin (group 1) or simultaneous therapy with josamycin and immunomodulator (group 3) considerable suppression of growth and elimination of both main pathogens and members of microbiota. Use of immunomodulator (group 2) in some cases resulted elimination of main pathogens and associated opportunistic microflora. CONCLUSION: Microbiological monitoring in 97% cases demonstrated therapeutic effect of immunomodulator Superlymph on urogenital infections associated with Chlamydia and Mycoplasma and disbiotic microbiota of urogenital tract.


Assuntos
Antibacterianos/administração & dosagem , Peptídeos Catiônicos Antimicrobianos/administração & dosagem , Infecções por Chlamydia/tratamento farmacológico , Chlamydia , Citocinas/administração & dosagem , Infecções por Mycoplasma/tratamento farmacológico , Mycoplasma , Prostatite/tratamento farmacológico , Cervicite Uterina/tratamento farmacológico , Vulvovaginite/tratamento farmacológico , Adulto , Infecções por Chlamydia/microbiologia , Feminino , Humanos , Josamicina/administração & dosagem , Masculino , Pessoa de Meia-Idade , Infecções por Mycoplasma/microbiologia , Prostatite/microbiologia , Cervicite Uterina/microbiologia , Vulvovaginite/microbiologia
2.
Ter Arkh ; 69(12): 76-8, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9503543

RESUMO

In lymphocytes of peripheral blood from 46 patients with various forms of lupus erythematosus measurements were made of histone fractions and DNA. It is proved that intranuclear characteristics of lymphoid cells can be used in the choice of treatment and assessment of its efficacy. Lupus erythematosus treatment with glucocorticoids (diprospan, diprospan + celeston) is effective in correction of intranuclear lymphocyte changes in this disease.


Assuntos
Glucocorticoides/uso terapêutico , Lúpus Eritematoso Sistêmico/terapia , Linfócitos/patologia , Magnetismo/uso terapêutico , Adolescente , Adulto , Divisão Celular , Núcleo Celular/química , Núcleo Celular/efeitos dos fármacos , Criança , Pré-Escolar , DNA/análise , Eletroforese em Gel de Poliacrilamida , Feminino , Histonas/análise , Humanos , Lúpus Eritematoso Discoide/sangue , Lúpus Eritematoso Discoide/terapia , Lúpus Eritematoso Sistêmico/sangue , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Masculino , Pessoa de Meia-Idade
3.
Ter Arkh ; 68(12): 82-4, 1996.
Artigo em Russo | MEDLINE | ID: mdl-9054053

RESUMO

The study was made of lisine- and arginine-rich histone fractions and DNA in lymphocytes of peripheral blood in patients with lupus erythematosus. The findings showed intranuclear changes of immunocompetent cells in various forms of the disease. The above parameters may be used in the diagnosis, evaluation of treatment efficacy, prognosis.


Assuntos
Histonas/sangue , Lúpus Eritematoso Discoide/sangue , Lúpus Eritematoso Sistêmico/sangue , Linfócitos/metabolismo , Doença Aguda , Adolescente , Adulto , Criança , Pré-Escolar , Doença Crônica , Feminino , Histonas/classificação , Humanos , Leucemia/sangue , Leucemia Linfocítica Crônica de Células B/sangue , Linfócitos/química , Transtornos Linfoproliferativos/sangue , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...